Thread Rating:
  • 0 Vote(s) - 0 Average
  • 1
  • 2
  • 3
  • 4
  • 5
Pharmaceutical Patent Policy
#4
How would you feel about some post-patent system that guarantees some percent of production costs (as independently determined by an auditor if necessary) go to the originator? Like say it costs 12 cents a pill to manufacture Vibralux, then a 20% fee to the original company would mean tacking another 2.4 cents onto that to send to the innovators. It wouldn't be as high as when the original company is selling them for 50 cents a pill, but it would prevent them from ever losing out completely.


The reason for basing it on production cost rather than a license negotiation (or patent) is so that if a company innovates on their own, reducing production costs, they can reap benefits fully, whereas if the fee were independent of the manufacturing cost, there's that much less incentive to improve mfr.
Reply


Messages In This Thread
Pharmaceutical Patent Policy - by Swerve - 2010-10-05, 11:24 PM
Pharmaceutical Patent Policy - by Fiel - 2010-10-05, 11:46 PM
Pharmaceutical Patent Policy - by Swerve - 2010-10-06, 12:29 PM
Pharmaceutical Patent Policy - by Stereo - 2010-10-06, 12:52 PM
Pharmaceutical Patent Policy - by Fiel - 2010-10-06, 01:10 PM
Pharmaceutical Patent Policy - by Swerve - 2010-10-06, 01:33 PM

Forum Jump:


Users browsing this thread: 1 Guest(s)